{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T19:12:22Z","timestamp":1785006742519,"version":"3.55.0"},"reference-count":61,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"China Academy of Chinese Medical Sciences Initiative for Innovative Medicine","award":["No.2016-I2M-3-006"],"award-info":[{"award-number":["No.2016-I2M-3-006"]}]},{"name":"Capital Medical Development Research Fund","award":["No. 2020-2-4035"],"award-info":[{"award-number":["No. 2020-2-4035"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Gene dysfunction and immune cell infiltration play an essential role in the pathogenesis of idiopathic pulmonary arterial hypertension (IPAH). We aimed to investigate the immune landscape and novel differentially expressed genes (DEGs) of IPAH. In addition, potential druggable molecular targets for IPAH were also explored. In this study, the GSE117261 dataset was reanalyzed to explore the immune landscape and hub DEGs of IPAH. Lasso Cox regression analysis and receiver operating characteristic curve analysis were performed to detect the predictive value of IPAH. Additionally, the underlying drug targets for IPAH treatment were determined by drug\u2013gene analysis. IPAH was significantly associated with the transforming growth factor-\u03b2 (TGF-\u03b2) signaling pathway and Wnt signaling pathway as well as energetic metabolism dysfunction. We identified 31 upregulated and 39 downregulated DEGs in IPAH patients. Six hub genes, namely, SAA1, CCL5, CXCR1, CXCR2, CCR1, and ADORA3, were related to IPAH pathogenesis regardless of sex differences. Prediction model analysis showed that the area under the curve values of the hub DEGs except CXCR2 were all above 0.9 for distinguishing IPAH patients. In addition, the relative proportions of 5 subtypes of immune cells, namely, CD8+ T cells, CD4+ memory resting T cells, \u03b3 delta T cells, M1 macrophages, and resting mast cells, were significantly upregulated in the IPAH samples, while 6 subtypes of immune cells, namely, CD4+ naive T cells, resting NK cells, monocytes, M0 macrophages, activated mast cells, and neutrophils, were downregulated. Additionally, a total of 17 intersecting drugs targeting 5 genes, CCL5, CXCR1, CXCR2, CCR1, and ADORA3, were generated as potential druggable molecular targets for IPAH. Our study revealed the underlying correlations between genes and immune cells in IPAH and demonstrated for the first time that SAA1, CCL5, CXCR1, CCR1, and ADORA3 may be novel genetic targets for IPAH.<\/jats:p>","DOI":"10.3390\/genes12010125","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T11:39:55Z","timestamp":1611056395000},"page":"125","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Identification of Potential Risk Genes and the Immune Landscape of Idiopathic Pulmonary Arterial Hypertension via Microarray Gene Expression Dataset Reanalysis"],"prefix":"10.3390","volume":"12","author":[{"given":"Jing","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicheng","family":"Yang","sequence":"additional","affiliation":[{"name":"Pulmonary Vascular Disease Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1309-2667","authenticated-orcid":false,"given":"Yuejin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changming","family":"Xiong","sequence":"additional","affiliation":[{"name":"Pulmonary Vascular Disease Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.15829\/1560-4071-2016-5-5-64","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"37","author":"Galie","year":"2016","journal-title":"Russ. J. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"110355","DOI":"10.1016\/j.biopha.2020.110355","article-title":"Investigational pharmacotherapy and immunotherapy of pulmonary arterial hypertension: An update","volume":"129","author":"Yang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"j5492","DOI":"10.1136\/bmj.j5492","article-title":"Pulmonary arterial hypertension: Pathogenesis and clinical management","volume":"360","author":"Thenappan","year":"2018","journal-title":"BMJ"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Van Uden, D., Boomars, K., and Kool, M. (2019). Dendritic cell subsets and effector function in idiopathic and connective tissue disease-associated pulmonary arterial hypertension. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00011"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.chest.2020.01.013","article-title":"Genetics and other omics in pediatric pulmonary arterial hypertension","volume":"157","author":"Welch","year":"2020","journal-title":"Chest"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jamacardio.2020.0479","article-title":"Association of rare PTGIS variants with susceptibility and pulmonary vascular response in patients with idiopathic pulmonary arterial hypertension","volume":"5","author":"Wang","year":"2020","journal-title":"JAMA Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1161\/CIRCRESAHA.117.310967","article-title":"Biomedical informatics on the cloud: A treasure hunt for advancing cardiovascular medicine","volume":"122","author":"Ping","year":"2018","journal-title":"Circ. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1165\/rcmb.2018-0368OC","article-title":"Systems analysis of the human pulmonary arterial hypertension lung transcriptome","volume":"60","author":"Stearman","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2006.00483.x","article-title":"Skin gammadelta T-cell functions in homeostasis and wound healing","volume":"215","author":"Jameson","year":"2007","journal-title":"Immunol. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: Archive for functional genomics data sets--update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.20892\/j.issn.2095-3941.2018.0277","article-title":"A four-gene signature-derived risk score for glioblastoma: Prospects for prognostic and response predictive analyses","volume":"16","author":"Cao","year":"2019","journal-title":"Cancer Biol. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: A Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/bioinformatics\/btt019","article-title":"CluePedia Cytoscape plugin: Pathway insights using integrated experimental and in silico data","volume":"29","author":"Bindea","year":"2013","journal-title":"Bioinformatics"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"D808","DOI":"10.1093\/nar\/gks1094","article-title":"STRING v9.1: Protein-protein interaction networks, with increased coverage and integration","volume":"41","author":"Franceschini","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","article-title":"An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the reveal registry","volume":"142","author":"Benza","year":"2012","journal-title":"Chest"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/eurheartj\/eht072","article-title":"Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: A comparison between clinical subgroups","volume":"35","author":"Manes","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_19","first-page":"419","article-title":"Contextual determinants of TGF\u03b2 action in development, immunity and cancer. Nature reviews","volume":"19","author":"David","year":"2018","journal-title":"Mol. Cell. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3389\/fcell.2020.00260","article-title":"TGF-\u03b2;-induced endothelial to mesenchymal transition in disease and tissue engineering","volume":"8","author":"Ma","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/CIRCULATIONAHA.109.933762","article-title":"Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension","volume":"122","author":"Soon","year":"2010","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1701214","DOI":"10.1183\/13993003.01214-2017","article-title":"The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension","volume":"51","author":"Marsh","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Guignabert, C., and Humbert, M. (2020). Targeting transforming growth factor \u03b2 receptors in pulmonary hypertension. Eur. Respir. J., 2002341.","DOI":"10.1183\/13993003.02341-2020"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ijcard.2016.07.192","article-title":"Elevated levels of plasma transforming growth factor-\u03b21 in idiopathic and heritable pulmonary arterial hypertension","volume":"222","author":"Yan","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.addr.2010.09.012","article-title":"The Wnt signaling pathway in cellular proliferation and differentiation: A tale of two coactivators","volume":"62","author":"Teo","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"C415","DOI":"10.1152\/ajpcell.00057.2014","article-title":"Identification of a common Wnt-associated genetic signature across multiple cell types in pulmonary arterial hypertension","volume":"307","author":"West","year":"2014","journal-title":"Am. J. Physiol. Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1164\/rccm.201508-1678OC","article-title":"Critical genomic networks and vasoreactive variants in idiopathic pulmonary arterial hypertension","volume":"194","author":"Hemnes","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.113.301141","article-title":"Inflammation and Immunity in the Pathogenesis of Pulmonary Arterial Hypertension","volume":"115","author":"Rabinovitch","year":"2014","journal-title":"Circ. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jcp.1041600310","article-title":"Enhanced growth capacity of neonatal pulmonary artery smooth muscle cells in vitro: Dependence on cell size, time from birth, insulin-like growth factor I, and auto-activation of protein Kinase, C.J","volume":"160","author":"Dempsey","year":"1994","journal-title":"Cell. Physiol."},{"key":"ref_30","first-page":"263","article-title":"Much more than M1 and M2 macrophages, there are also CD169(+) and TCR(+) macrophages","volume":"6","author":"Olleros","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1165\/rcmb.2018-0232OC","article-title":"Carbonic anhydrase inhibition ameliorates inflammation and experimental pulmonary hypertension","volume":"61","author":"Hudalla","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/14779072.2016.1180976","article-title":"Challenges and opportunities in treating inflammation associated with pulmonary hypertension","volume":"14","author":"Voelkel","year":"2016","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.21037\/jtd-19-2842","article-title":"Comprehensive analysis of lncRNA-associated competing endogenous RNA network and immune infiltration in idiopathic pulmonary fibrosis","volume":"12","author":"Wang","year":"2020","journal-title":"J. Thorac. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm1452","article-title":"Decidual NK cells regulate key developmental processes at the human fetal-maternal interface","volume":"12","author":"Hanna","year":"2006","journal-title":"Nat. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1161\/CIRCULATIONAHA.112.110619","article-title":"Impaired natural killer cell phenotype and function in idiopathic and heritable pulmonary arterial hypertension","volume":"126","author":"Morrell","year":"2012","journal-title":"Circulation"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/resp.12152","article-title":"Professional killer cell deficiencies and decreased survival in pulmonary arterial hypertension","volume":"18","author":"Edwards","year":"2013","journal-title":"Respirology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"14500","DOI":"10.1038\/s41598-017-14202-5","article-title":"T cells upon activation promote endothelin 1 production in monocytes via IFN-\u03b3; and TNF-\u03b1","volume":"7","author":"Shinagawa","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.4049\/jimmunol.1900239","article-title":"Nonclassical monocytes sense hypoxia, regulate pulmonary vascular remodeling, and promote pulmonary hypertension","volume":"204","author":"Yu","year":"2020","journal-title":"J. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fmed.2018.00217","article-title":"The role of neutrophils and neutrophil elastase in pulmonary arterial hypertension","volume":"5","author":"Taylor","year":"2018","journal-title":"Front. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1161\/ATVBAHA.116.307634","article-title":"Neutrophil extracellular traps promote angiogenesis: Evidence from vascular pathology in pulmonary hypertension","volume":"36","author":"Aldabbous","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1183\/09031936.00148311","article-title":"Iloprost improves endothelial barrier function in lipopolysaccharide-induced lung injury","volume":"41","author":"Birukova","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12950-015-0099-7","article-title":"The role of phosphodiesterase-5 inhibitors in prostatic inflammation: A review","volume":"12","author":"Peixoto","year":"2015","journal-title":"J. Inflamm."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.gene.2016.02.044","article-title":"Serum amyloid A1: Structure, function and gene polymorphism","volume":"583","author":"Sun","year":"2016","journal-title":"Gene"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s41590-020-0698-1","article-title":"Serum amyloid A is a soluble pattern recognition receptor that drives type 2 immunity","volume":"21","author":"Smole","year":"2020","journal-title":"Nat. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Gan, X.-W., Wang, W.-S., Lu, J.-W., Ling, L.-J., Zhou, Q., Zhang, H.-J., Ying, H., and Sun, K. (2020). De novo synthesis of SAA1 in the placenta participates in parturition. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01038"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cell.2019.11.026","article-title":"Serum amyloid a proteins induce pathogenic Th17 cells and promote inflammatory","volume":"180","author":"Lee","year":"2020","journal-title":"Dis. Cell."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1073\/pnas.1322357111","article-title":"Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis","volume":"111","author":"Lu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/ni.1942","article-title":"Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A","volume":"11","author":"Arscott","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.4049\/jimmunol.1402164","article-title":"Ex vivo and in vitro effect of serum amyloid a in the induction of macrophage M2 markers and efferocytosis of apoptotic neutrophils","volume":"194","author":"Sun","year":"2015","journal-title":"J. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1189\/jlb.3VMR0315-080R","article-title":"Emerging functions of serum amyloid A in inflammation","volume":"98","author":"Ye","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1164\/rccm.2106007","article-title":"CX3C chemokine fractalkine in pulmonary arterial hypertension","volume":"165","author":"Balabanian","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1164\/ajrccm.165.4.2012112","article-title":"Chemokine RANTES in severe pulmonary arterial hypertension","volume":"165","author":"Zarka","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/CIRCRESAHA.118.313911","article-title":"Discovery of distinct immune phenotypes using machine learning in pulmonary arterial hypertension","volume":"124","author":"Sweatt","year":"2019","journal-title":"Circ. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: A new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2249.2012.04638.x","article-title":"Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells","volume":"170","author":"Nakano","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1165\/rcmb.2015-0402OC","article-title":"Bone morphogenic protein type 2 receptor mutation-independent mechanisms of disrupted bone morphogenetic protein signaling in idiopathic pulmonary arterial hypertension","volume":"55","author":"Barnes","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIRCULATIONAHA.115.020696","article-title":"Bone morphogenetic protein receptor type 2 mutation in pulmonary arterial hypertension: A view on the right ventricle","volume":"133","author":"Trip","year":"2016","journal-title":"Circulation"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.yjmcc.2018.01.016","article-title":"CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation","volume":"116","author":"Nie","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nrd1983","article-title":"Adenosine receptors as therapeutic targets","volume":"5","author":"Jacobson","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.4049\/jimmunol.1800618","article-title":"TLR-Induced IL-12 and CCL2 Production by Myeloid Cells Is Dependent on Adenosine A3 Receptor\u2013Mediated Signaling","volume":"202","author":"Veth","year":"2019","journal-title":"J. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"D\u2019Antongiovanni, V., Fornai, M., Pellegrini, C., Benvenuti, L., Blandizzi, C., and Antonioli, L. (2020). The Adenosine System at the Crossroads of Intestinal Inflammation and Neoplasia. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21145089"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/12\/1\/125\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:13:03Z","timestamp":1760159583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/12\/1\/125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["genes12010125"],"URL":"https:\/\/doi.org\/10.3390\/genes12010125","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]}}}